INOVIO PHARMACEUTICALS INC - COM NEW (INO) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q2 2024

Type / Class
Equity / COM NEW
Symbol
INO on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INOVIO PHARMACEUTICALS INC - COM NEW (INO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q2 0 $0 -$143,618 0
2024 Q1 10,350 $143,618 -$26,894,375 $13.88 3
2023 Q4 49,572,574 $25,279,551 -$2,592,583 $0.51 102
2023 Q3 55,598,624 $21,628,024 -$6,261,076 $0.39 121
2023 Q2 71,547,012 $31,944,952 -$26,196,770 $0.45 129
2023 Q1 121,763,691 $99,817,639 -$8,870,811 $0.82 171
2022 Q4 127,334,960 $198,635,277 +$16,265,606 $1.56 178
2022 Q3 116,953,127 $201,734,472 +$5,175,525 $1.72 153
2022 Q2 113,348,043 $196,098,430 +$35,548,764 $1.73 150
2022 Q1 91,979,719 $330,238,970 +$12,204,256 $3.59 166
2021 Q4 85,945,965 $428,901,612 +$38,226,055 $4.99 185
2021 Q3 77,497,222 $554,890,125 +$25,218,463 $7.16 190
2021 Q2 73,704,136 $683,073,058 -$10,546,211 $9.27 199
2021 Q1 74,776,166 $693,637,046 +$85,503,155 $9.28 205
2020 Q4 65,783,945 $582,256,996 +$25,806,749 $8.85 208
2020 Q3 62,386,793 $723,680,117 +$24,644,769 $11.60 204
2020 Q2 56,597,780 $1,524,080,527 +$426,708,151 $26.95 205
2020 Q1 43,970,598 $327,149,479 -$48,428,098 $7.44 143
2019 Q4 48,437,900 $159,843,385 +$8,013,929 $3.30 97
2019 Q3 46,376,395 $95,165,071 +$1,004,732 $2.05 108
2019 Q2 45,743,844 $134,488,010 +$7,197 $2.94 116
2019 Q1 45,708,039 $170,463,101 +$37,582,880 $3.73 118
2018 Q4 35,629,153 $142,522,500 +$7,681,542 $4.00 118
2018 Q3 32,712,469 $181,861,327 +$22,108,861 $5.56 123
2018 Q2 28,889,565 $113,249,697 -$5,662,704 $3.92 119
2018 Q1 30,097,890 $141,830,628 +$8,431,607 $4.71 119
2017 Q4 28,590,514 $118,082,334 -$3,301,322 $4.13 119
2017 Q3 29,077,299 $184,292,078 +$41,976,243 $6.34 121
2017 Q2 22,330,843 $175,081,580 +$18,766,216 $7.84 112
2017 Q1 19,953,056 $132,080,603 +$31,892,780 $6.62 98
2016 Q4 20,434,258 $141,792,175 -$8,193,932 $6.94 122
2016 Q3 21,155,825 $197,166,230 +$1,365,311 $9.32 120
2016 Q2 21,015,547 $194,190,065 +$8,473,449 $9.24 129
2016 Q1 20,029,148 $174,278,402 -$23,695,690 $8.71 111
2015 Q4 23,289,305 $156,499,504 -$10,052,450 $6.72 121
2015 Q3 24,642,013 $142,388,816 +$5,068,092 $5.78 110
2015 Q2 23,625,258 $192,774,575 +$39,337,717 $8.16 102
2015 Q1 18,804,240 $153,628,859 +$6,904,571 $8.16 97
2014 Q4 17,580,872 $161,369,763 +$32,956,071 $9.18 90
2014 Q3 13,961,679 $137,483,200 +$24,119,964 $9.85 82
2014 Q2 11,477,641 $124,029,292 +$123,963,291 $10.81 73